Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130:410–23.

CAS  PubMed  PubMed Central  Google Scholar 

Kumar R, Godavarthy PS, Krause DS. The bone marrow microenvironment in health and disease at a glance. J Cell Sci. 2018;131:jcs201707.

PubMed  Google Scholar 

Kandarakov O, Belyavsky A, Semenova E. Bone marrow niches of hematopoietic stem and progenitor cells. J Mol Sci. 2022;23:4462.

Google Scholar 

Mendez-Ferrer S, Bonnet D, Steensma DP, Hasserjian RP, Ghobrial IM, Gribben JG, et al. Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020;20:285–98.

CAS  PubMed  PubMed Central  Google Scholar 

Pinho S, Frenette PS. Haematopoietic stem cell activity and interactions with the niche. Nat Rev Mol Cell Biol. 2019;20:303–20.

CAS  PubMed  PubMed Central  Google Scholar 

Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, et al. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts. Nature. 2014;506:240–4.

CAS  PubMed  PubMed Central  Google Scholar 

Kode A, Mosialou I, Manavalan SJ, Rathinam CV, Friedman RA, Teruya-Feldstein J, et al. FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia. 2016;30:1–13.

CAS  PubMed  Google Scholar 

Dong L, Yu WM, Zheng H, Loh ML, Bunting ST, Pauly M, et al. Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature. 2016;539:304–8.

PubMed  PubMed Central  Google Scholar 

Walkley CR, Olsen GH, Dworkin S, Fabb SA, Swann J, McArthur GA, et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell. 2007;129:1097–110.

CAS  PubMed  PubMed Central  Google Scholar 

Walkley CR, Shea JM, Sims NA, Purton LE, Orkin SH. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell. 2007;129:1081–95.

CAS  PubMed  PubMed Central  Google Scholar 

Kim YW, Koo BK, Jeong HW, Yoon MJ, Song R, Shin J, et al. Defective Notch activation in microenvironment leads to myeloproliferative disease. Blood. 2008;112:4628–38.

CAS  PubMed  Google Scholar 

Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, et al. Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2006;12:511–7.

Google Scholar 

Wiseman DH. Donor cell leukemia: a review. Biol Blood Marrow Transpl. 2011;17:771–89.

Google Scholar 

Florez MA, Tran BT, Wathan TK, DeGregori J, Pietras EM, King KY. Clonal hematopoiesis: mutation-specific adaptation to environmental change. Cell Stem Cell. 2022;29:882–904.

CAS  PubMed  PubMed Central  Google Scholar 

Pittenger MF, Discher DE, Peault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22.

PubMed  PubMed Central  Google Scholar 

Mabuchi Y, Okawara C, Mendez-Ferrer S, Akazawa C. Cellular heterogeneity of mesenchymal stem/stromal cells in the bone marrow. Front Cell Dev Biol. 2021;9:689366.

PubMed  PubMed Central  Google Scholar 

Wang Y, Chen X, Cao W, Shi Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014;15:1009–16.

CAS  PubMed  Google Scholar 

Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5:e10088.

PubMed  PubMed Central  Google Scholar 

Plakhova N, Panagopoulos V, Vandyke K, Zannettino ACW, Mrozik KM. Mesenchymal stromal cell senescence in haematological malignancies. Cancer Metast Rev. 2023;42:277–96.

Google Scholar 

Lee MW, Ryu S, Kim DS, Lee JW, Sung KW, Koo HH, et al. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges. Leukemia. 2019;33:597–611.

PubMed  PubMed Central  Google Scholar 

Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, Schoonmaker JA, et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature. 2010;464:852–7.

CAS  PubMed  PubMed Central  Google Scholar 

Xiao P, Dolinska M, Sandhow L, Kondo M, Johansson AS, Bouderlique T, et al. Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm. Blood Adv. 2018;2:534–48.

CAS  PubMed  PubMed Central  Google Scholar 

Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR. Defining ‘chromosomal instability. ’ Trends Genet. 2008;24:64–69.

CAS  PubMed  Google Scholar 

Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20:R285–295.

CAS  PubMed  PubMed Central  Google Scholar 

de Oliveira Lisboa M, Brofman PRS, Schmid-Braz AT, Rangel-Pozzo A, Mai S. Chromosomal instability in acute myeloid leukemia. Cancers. 2021;13:2655.

CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF, Cantley LC. The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment. Cell. 2018;174:1347–60.

CAS  PubMed  PubMed Central  Google Scholar 

Korn C, Méndez-Ferrer S. Myeloid malignancies and the microenvironment. Blood. 2017;129:811–22.

CAS  PubMed  PubMed Central  Google Scholar 

de Jong MME, Chen L, Raaijmakers MHGP, Cupedo T. Bone marrow inflammation in haematological malignancies. Nat Rev Immunol. 2024;24:543-58. .

Lepage CC, Morden CR, Palmer MCL, Nachtigal MW, McManus KJ. Detecting chromosome instability in cancer: approaches to resolve cell-to-cell heterogeneity. Cancers. 2019;11:226.

CAS  PubMed  PubMed Central  Google Scholar 

ISCN 2024: An International System for Human Cytogenomic Nomenclature (2024). S.Karger AG.

Heng HH, Regan SM, Liu G, Ye CJ. Why it is crucial to analyze non clonal chromosome aberrations or NCCAs?. Mol Cytogenet. 2016;9:15.

PubMed  PubMed Central  Google Scholar 

Neuse CJ, Lomas OC, Schliemann C, Shen YJ, Manier S, Bustoros M, et al. Genome instability in multiple myeloma. Leukemia. 2020;34:2887–97.

PubMed  Google Scholar 

Xu S, De Veirman K, De Becker A, Vanderkerken K, Van Riet I. Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?. Leukemia. 2018;32:1500–14.

PubMed  PubMed Central  Google Scholar 

Todoerti K, Lisignoli G, Storti P, Agnelli L, Novara F, Manferdini C, et al. Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease. Exp Hematol. 2010;38:141–53.

CAS  PubMed  Google Scholar 

Guo J, Zhao Y, Fei C, Zhao S, Zheng Q, Su J, et al. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells. Cell Death Dis. 2018;9:512.

PubMed  PubMed Central  Google Scholar 

Arnulf B, Lecourt S, Soulier J, Ternaux B, Lacassagne MN, Crinquette A, et al. Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia. 2007;21:158–63.

CAS  PubMed  Google Scholar 

Garayoa M, Garcia JL, Santamaria C, Garcia-Gomez A, Blanco JF, Pandiella A, et al. Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia. 2009;23:1515–27.

CAS  PubMed  Google Scholar 

Maiso P, Mogoll¢n P, Ocio EM, Garayoa M. Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression. Cancers 2021;13:2542.

PubMed  PubMed Central  Google Scholar 

Iannozzi NT, Marchica V, Toscani D, Burroughs Garcìa J, Giuliani N, Storti P. Molecular features of the mesenchymal and osteoblastic cells in multiple myeloma. Int J Mol Sci. 2022;23:15448.

PubMed  PubMed Central  Google Scholar 

Conforti A, B